日本産科婦人科学会雑誌
文字サイズ
第41巻 第8号 目次
表紙
目次
第42回総会ならびに学術講演会予告 (第3回)
第43回学術講演会特別講演演者の推薦
第43回学術講演会シンポジウム課題の決定ならびに担当希望者公募
第44回学術講演会シンポジウム課題公募
臨床・研究遂行上倫理的に注意すべき事項に関する見解の一覧
投稿規定
婦人科がん治療の新しい試み : 温熱療法を中心として
骨盤内腫瘍悪性度診断への画像解析
SURGICAL-PATHOLOGIC STAGING OF ENDOMETRIAL CARCINOMA
子宮内膜症をめぐる諸問題
子宮内膜症性不妊に対する治療法の検討 (<シンポジウム> 子宮内膜症をめぐる諸問題)
子宮内膜症の生化学的特性に関する基礎ならびに臨床的研究 : 正常子宮内膜との対比 (<シンポジウム> 子宮内膜症をめぐる諸問題)
子宮内膜症の内分泌療法確立に関する研究 (<シンポジウム>子宮内膜症をめぐる諸問題)
子宮内膜症と妊孕性に関する内視鏡学的研究 (<シンポジウム>子宮内膜症をめぐる諸問題)
討論 (<シンポジウム>子宮内膜症をめぐる諸問題)
婦人科悪性腫瘍に対するstaging laparotomy
不育症の総合的検索とその治療
細胞の増殖と分化 : 幼若肝細胞をモデルとして
胎児から新生児へ : 胎児カテコラミンの意義
思春期の発育とその異常 : 特に内分泌を中心として
更年期の諸問題 : 卵巣機能をめぐって
感染症診療における化学療法の問題 : 抗菌剤の基礎とその使い分け
女性の生涯よりみた肥満
Program of the 41st Annual Scientific Meeting
1 Initial trial and its pharmacokinetics of intra-arterial ciplatin with venous hemodialysis in gynecologic cancer patients.
2 Selective intra-arterial chemoinfusion and chemoembolization using cisplatin (CDDP) in combination with angiotensin II pressor for recurrent gynecologic cancer.
3 Two-route chemotherapy (TRC) using cisplatin (DDP) and its antidote, sodium thiosulfate (STS), combined with angiotensin II (AT-II) against peritoneally disseminated cancer in rats.
4 Ultraselective Transcatheter-Arterial-Chemo-Embolization on Uterine Cervical Cancers.
5 Consecutive Intraarterial Infusion in Patients with cervical cancer recurrent in the pelvis after radiation.
6 Perfusion Pattern Using of ^<99m>Tc-MAA in Intra-Arterial Infusion Chemoterapy for Uterine Cervical Cancer.
7 Clinicopathologic study in preoperative CDDP intra-arterial infusion chemotherapy in combination with pressor for cervical cancer.
8 Experimental studies on the chemotherapy of gynecological neoplasm by means of adriamycin entrapped in liposomes.
9 IAP-based combination chemotherapy for patients with gynecologic cancer derived from the extended mullerian system.
10 Comparative studies of anti-tumor activity of CDDP and CDDP analogues.
11 Studies on 5-FU sensitivities of uterine cervical cancer. : Comparison between squamous cell carcinoma and adenocarcinoma.
12 Clinical and experimental study on postoperative adjuvant chemotherapy for cervical adenocarcinoma.
13 The combination effect of UFT and CDDP
14 Oncogenic transformation by HPV 16 or HPV 18 : The possibility of "hit and run" oncogenesis.
15 The presence of human papillomavirus (HPV) DNA in squamous metaplasia, dysplasia and carcinoma in situ (CIS).
16 The physical state of human papillomavirus type 16 DNA in cervical dysplasia and carcinoma in situ.
17 Localization of HPV DNA and late genes L1/L2mRNA in the vulva neoplasia by in situ hybridization.
18 Study of the localization of HPV types 16 and 18 E6/E7mRNA in the precancerous lesions and carcinoma in situ of uterine cervix by in situ hybridization.
19 Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line.
20 Association of human papillomavirus types with histological types of cervical carcinomas.
21 Analysis of HPV52b sequence and geographical difference in the distribution of HPV52b in Japan.
22 Histogenesis of adenocarcinoma of the uterine cervix : a study of HPV DNA by in situ hybridization.
23 Analysis and clinical application of monoclonal antibody against a human uterine cervical cancer cell line OMC-1.
24 The production of monoclonal antibody reactive with cervical adenocarcinoma of the uterus.
25 Basic studies on application of two kinds of monoclonal antibodies against endometrial cancer to treatment of cancer.
26 Establishment and characterization of a cell line (OMC-6) originating from a human endometrial stromal sarcoma.
27 Establishment of human uterine sarcoma in nude mice.
28 Differentiation induction of human embryonal carcinoma cell by hexamethylene bisacetamide in vitro.
29 Induction of specific lymphokine-activated killer cells in a nude mouse model bearing human ovarian cancer cell line capable of forming ascites.
30 Sensitibity to cytokines and anticancer agents of a newly established cell line derived from human uterine cervical adenocarcinoma.
31 In vivo chemosensitivity test of human uterine cervical adenocarcinoma successively transplanted into nude-mice.
32 Introduction of a normal human chromosome 1 suppresses various transformed phenotypes of an uterine endometrial carcinoma cell line.
33 Analysis of EGF receptor and effect of EGF on the growth and the response of steroid hormones of the endometial adenocarcinoma cell line (OMC-2).
34 MPA inhibits ADM-resistance of endometrial cancer
35 Growth stimulation by insulin in human endometrial cancer cells.
36 Inhibition of metastasis in gynecologic molignant tumors by medroxyprogesterone acetate with reference to tumor angiogenesis factor and fiboblast growth factor.
37 The glycolipids in an endometrial cancer cell line.
38 Immunohistochemical localization of extracellular matrix in Endometriosis.
39 Correlation of the prognostic factors and co-exitance of endometrial hyperplasia in endometrial carcinoma.
40 Cytological studys for endometrial hyperplasia and endometrial adenocarcinoma in early stage.
41 The management of stage III endometrial carcinoma.
42 Evaluation of X-ray CT and Magnetic Resonance Imaging in the Diagnosis of Endometrial Carcinoma.
43 Reclassification of the stage 1b and the stage 1bocc carcinoma of uterus by NEW FIGO DEFINITION.
44 Histopathological studies on the factors influencing nodal metastases of cervical carcinoma.
45 Investigation of para-aortic lymphnode metastases in gynecologic cancers.
46 Clinicopathological study of adenocarcinoma of the uterine cervix
47 Role of X-ray CT and Magnetic Resonance Imaging in Evaluation of Spread of Uterine Cervical Carcinoma.
48 Ultrasonically guided fine needle aspiration biopsy (FNAB) for pelvic and paraaortic lymphnodes swelling of gynecologic cancer.
49 Transrectal Ultrasonically Guided Fine-Needle Aspiration Biopsy for Cervical Canser.
50 Circadian rhythm of pineal hormone (Melatonin) during perinatal period
51 A study on Maternal and Fetal Circulation Dynamics during Ergometer Exercise
52 Effects of maternal exercise using bicycle ergometer on oxygen consumption, maternal and fetal heart rate, and ECG change during swimming.
53 One of the Maternal Blood Pressure Monitor System during labor.
54 The changes of cerebral hemodynamics in late pregnant women in different positions.
55 Preeclampsia induced alterations of sodium transport systems in erythrocte membrane.
56 A study of Myometrial Glycogen Metabolism in Pregnant Rat Myometrium
57 Study with metoclopramide (MCP) loading test during pregnancy and puerperium for evaluation of lactating capacity.
58 Ovarian function during postpartum period.
59 Characteristics in the metabolism during puerperium : Insulin resistance in isolated adipocytes during puerperium.
60 Concentrated vitamin K in breast milk and the effect on infants after vitamin K prescription to mothers.
61 A clinical study on the mode of feeding in infants born to HTLV-1 carrier.
62 IgG transport within the human placenta.
63 Changes of lactate dehydrogenase activity and isozyme in placental and umbilical cord tissues during pregnancy and delivery.
64 Induction of preterm delivery with antiprogesterone RU-486 in the late pregnant rat. : With reference to collagenolytic enzyme activity in the uterine cervix
65 The pathophysiology prediction of fetal asphyxia
66 Evaluation of hemodynamics at fetal distress by pulsed Doppler method.
67 Cephalic computed tomography (CT) of 119 neonates born with transvaginal breech delivery, and their long-term follow-ups.
68 Variation of β-endorphine(EP)/ACTH ratio in plasma of pregnant women without labor and with labor.
69 A study of prolactin secretion in the maternal circulation during parturition.
70 Analysis of prostaglandins in the urine of women in labor using high performance liquid chromatography (HPLC).
71 Changes of 13,14-dihydro-15-keto-prostaglandin F_<2α> and oxytocin levels in amniotic fluid at late pregnancy and during labor.
72 Quantitative changes and qualitative differences in oxytocin receptors in various experimental steroid environment.
73 A Study of Oxytocin Release in Normal Laboring Women.
74 Relationship between concentrations of oxytocin receptor and oxytocin-stimulated productions of prostaglandins in the utero-placental tissues of late pregnant rabbits.
75 Comparative study of the 25(OH) D_3 conversion enzymes in the human term placentas of AFD and Light for Dates infants.
76 Effect of maternal albumin infusion for fetal blood circulation.
77 The effect of fatty acid (FA) administration during pregnancy, especially essential FA, lipid peroxide and anti-oxidant in feto-material unit.
78 The effect of administered EPA on pregnant and neonatal rabbits.
79 Serum 1.5-anhydro-D-glucitol levels in pregnant women and newborns.
80 Differences of prostagrandin dehydrogenase activity between pregnant, postpartum and nonpregnant rats in placenta, lung, kidney and gastric mucosa.
81 Urinary 11-Dehydro TXB_2 during normal pregnancy.
82 PGI_2 production and Ca^<++> kinetics in vascular endothelial cells of pregnant rats with STZ induced diabetes.
83 Change of antilipoperoxide mechanism in diabetic pregnant rats by administering vitamin E.
84 The effect of maternal blood glucose level on feto-maternal calcium metabolism in diabetic pregnancy.
85 Serum concentration of 1-deoxyglucose during pregnancy and the puerperium and evaluation of the compound as a parameter of abnormal carbohydrate metabolism.
86 Effect of time difference between insulin injection and food intake on maternal glucose values in five insulin required pregnant diabetes.
87 The effects of insulin antibodies on fetus in diabetic pregnancy.
88 Studies of the development of GDM : occurrence in repeat pregnancy and herditary predisposition.
89 Fetal erythrocyte adenosine triphosphate levels and deformability at delivery.
90 Relation between kinin-kallikrein and contact factors during parturition.
91 Analysis of Maternal and Fetal Blood Rheological Factors.
92 Isolation and characterization of an anticoagulant protein (Calphobindin-III) from human placenta.
93 Plasma replacement therapy (double filtration plasmapheresis, DFPP) for pregnancy with severe Rh(D) blood type incompatibility.
94 Studies of dynamics and synthesis of new placental protein PP19.
95 Diagnosis of amniotic embolism by using the fluorescent characteristic of coproporphyrin, a component of fetal urine.
96 Clinical significance of polymorphism in thrombomodulin gene.
97 Management of delivery in women with hereditary antithrombin III deficiency.
98 A study of the CDDP dosage for progressive ovarian cancer with reference to alteration of blood coagulation during remission therapy applied to patients with a recurrence.
99 The cross resistance of the platinum derivatives in human ovarian cancer cells in vitro.
100 Problems of Cisplatin Therapy for Ovarian Cancer from the viewpoint of Long-Term Prognosis.
101 Effect of medroxyprogesterone acetate on side effects of CAP therapy for gynecological malignant tumors.
102 Efficacy of intermittent CDDP administration as maintenance chemotherpay for ovarian cancer.
103 Effect of carboplatin (single and combination with ADM and CPA) and results of randomized trial with cisplatin combination chemotherapy in the treatment of advanced ovarian cancer.
104 Pharmacokinetic study of carboplatin, cisplatin and 254-S in intraperitoneal infusion.
105 Comparative study on effect of anticancer drug method and medication method on ovarian cancer : Significance of intraperitoneal chemotherapy
106 Therapeutic schedule to improve the long term prognosis of ovarian cancer patients.
107 Hyperthermochemotherapy in ovarian cancers and its effectiveness.
108 Follow-up laparoscopies (LS) in patients with ovarian cancer : Application to individualization of additional chemotherapy after initial treatment
109 Solitary aortic nodal metastases limited to the level below inferior mesenteric artery in ovarian cancer.
110 Study on the new FIGO-staging of the ovarian carcinomas.
111 Clinical study of second-look operation (SLO) for ovarian carcinoma.
112 Antitumor effects of 12-OH-Δ^7-prostaglandin(PG)-A_1 analogue on human ovarian cancer transplanted in nude mice.
113 Immunohistochemical study on MKS-15 and its usefulness as a tumor marker for ovarian cancer.
114 Study on usefulness of new tumor marker, CA 72-4, in ovarian mucinous cystadenocarcinoma.
115 Analysis of glycosphingolipids in ovarian tumors.
116 Terminal sugar molecules of alpha-fetoprotin (AFP) in yolk sac tumor.
117 Effects of gonadotropin on malignant ovarian neoplasms.
118 Role of MRI in diagnosis of ovarian tumor.
119 Estrogen production in common epithelial tumors of the ovary.
120 Krukenberg tumor is an endocrine tumor?
121 Biological properties of cancer and stromal cells in Krukenberg tumor.
122 Clinicopathological study of malignant ovarian germ cell tumor.
123 Establishment of the drug-resistant ovarian cancer cell line and their characterization in vitro.
124 The mechanism of resistance of human ovarian carcinoma to cisplatin and overcoming by calmodulin antagonists (W-5, W-7).
125 Mechanism of clinical resistance to chemotherapy in ovarian cancer.
126 Individuation of chemotherapy for malignant ovarian carcinoma using newly established sensitivity test of anti-cancer agent.
127 A six-day subrenal capsule assay for predictive testing of ovarian cancer.
128 Clinical evaluation of subrenal capsule assay (SRC) in ovarian cancer.
129 Cross resistance of CDDP and new CDDP analogues and the effect of diprydamole on the cytotoxicity of these agents in human ovarian cancer cell lines, A2780 and CDDP resistant 2780-cp
130 Overcoming of natural resistance of ovarian clear cell carcinoma by calcium antagonist in vitro.
131 Immunohistochemical evaluation of ras and myc oncogene expression in common epithelial tumors of ovary.
132 Origin of ovarian teratoma by DNA fingerprinting.
133 Flow-cytometric analysis of DNA ploidy in ovarian cancer.
134 Correlation between CDDP Resistance and The Expression of Glutathione S-Transferase-π Gene in Ovarian Cancer Cell Lines.
136 Examination of the relationship between infiltration of T cells and proliferative cells in tissues of endometrial cancer.
137 Augmentative effect of lentinan on immune responses of patients with gynecologic cancer.
138 The Role of tumor necrosis factor in the cascade of T-lymphocytes and monocytes in gynecological cancer patients.
139 The significance of killer T cell activity specific to Epstein-Barr virus in patients with carcinoma of the female gential organ.
140 Establishment and characterization of human monoclonal anti-phospholipid antibody by Ebstein-Barr virus (EBV) transformation.
141 Establishment of anti-tumor CD4^+ and CD8^+ T cell lines and analysis of the mechanisms of their tumor cell lysis.
142 Changes of lymphocyte subsets and ADCC/NK activities in advanced cervical cancer with maintenance immunotherapy (SPG, OK-432).
143 Studies on clinical significance of type III procollagen peptide in sera as tumor marker in patients with cervical cancer.
144 Characterization of glycoproteins containing CA125 epitope from ovarian tumor fluid amnion and decidua.
145 A new monoclonal antibody lG12, elucidation of recognition antigen and investigation of its clinical significance as a tumor marker.
146 Effects of PHA on the structuredness of cytoplasmic matrix (SCM) in peripheral lymphocytes obtained from ovarian cancer patients : Theoretical evaluation using flow cytometer.
147 An experimental study for anticancer agent sensitivity test in human endometrial cancer cell-line by BrdU/DNA and Ki-67/DNA assay using flow cytometry.
148 Effect of Epidermal growth factor (EGF) on functional maturation of fetal hepatocytes in rats.
149 Studies on the regulatory mechanism of IGF-I circulating forms in fetal life.
150 Significance of nerve growth factor (NGF) in the perinatal period.
151 Evaluation of mitochondrial electron transport system in the brain, heart and liver of IUGR rats on perinatal period.
152 Effect of maternal L-Dopa administration on fetal catecholamine metabolism.
153 Serotonin metabolism in fetus and amniotic fluid in toxemia of pregnancy.
154 Study in tryptophan metabolism during the perinatal period, using new analytical method.
155 Metabolism of Tryptophan during the perinatal period.
156 A study on changes of ω3 and ω6 essential fatty acid in rat fetuses and newborns.
157 Six essential elements in maternal and cord blood and outcome of human pregnancy.
158 Serum bone γ-glutamic acid containing protein during the fetal development.
159 Electrophysiological characteristics of myocytes implanted into the renal capsular space of the rat and their relation to sympathetic innervation.
160 The indication of therapeutic medication and surgical approach for suffering fetus and its management in our institute.
161 ARTIFICIAL SURFACTANT TREATMENT AFTER LUNG LAVAGE WITH FLUOROCARBON IN HUMAN MECONIUM ASPIRATED RATS.
162 Basic consideration about intrauterine curative therapy for twin transfusion syndrome.
163 The effect of transplacental digitalization on nonimmunologic hydrops fetalis due to cardiac failure.
164 Relationship between RI values in the umbilical artery and the outcome in cases with hydrops fetalis.
165 Acute effect of nicotine and smoking on feto-maternal circulation in pregnant guinea pig.
166 Measurement of the carotid arterial blood flow of the goat fetus in the extra-uterine incubation system.
167 The endocrine responses of the goat fetus to extrauterine incubation.
168 Effects of cardiopulmonary bypass during pregnancy on a fetuses : acute animal model.
169 The effect of maternal oxygen administration on fetal blood gas status.
170 Fetal sleep state and breathing adaptation to anemia.
171 Fetal blood flow redistribution after repeated umbilical cord compression in sheep experiments.
172 Arginine vasopressin and angiotensin II on hemodynamics in fetal lamb.
173 Cardiovascular effect of Arginine Vasopressin (AVP) in newborn piglets during hypoxia.
174 Changes in fetal heart rate, short term and long term variabilities during persisted hypoxemia in chronically instrumented lamb fetuses.
175 The placental sluice flow mechanism caused by maternal supine position in late pregnancy.
176 A correlational study of umbilical arterial resistance index and feto-placental function.
177 Obstetrical management of the high-risk pregnancy utilizing the pulse Doppler blood flow analysis.
178 Prediction of intrauterine growth retardation (IUGR) with pulsed Doppler method and correlation between placental small arteries and IUGR.
179 Study of a Basic Plan of Therapy of IUGR Based on Fetoplacental Hemodynamics and Constructional Changes of Umbilical Cord and Placenta.
180 Analysis of the circulatory hemodynamics and perinatal care of IUGR fetuses and these neonates.
181 Antenatal analysis of the cardiac function of fetus with arrhythmias.
182 Study of fetal response to Vibro-Acoustic Stimulation.
183 Human fetal response to Vibro Acoustic Stimulation test (VAST) near term.
184 Changes in neonatal auditory brain stem response (ABR) : Serial measurement in premature and normal infants.
185 Measurement of time lag of fetal movement and transient fetal heart rate rise by ultrasonic Dopplar actcardiogram.
186 Pharmacodynamic study of UTI used in fetal distress therapy.
187 Correlation between morphological changes of fetal adrenal gland and maternal E_2-S and CBG levels.
188 Appearance of bradycardia and apnea in premature baby.
189 Urinary metabolites of coagulant factors in preterm and term infants.
190 On developing the on-line expert system for neonatal intensive care monitoring.
191 Detection of human papillomavirus DNA in vaginal intraepithelial neoplasia.
192 Localization of HPV6b proteins in Condyloma acuminata.
193 Localization of the charge-dependent materno-fetal barrier in the rat.
194 Effect of methylergometrine maleate (methergin) on electrical and mechanical activities of pregnant human myometrium.
195 Clinicopathological Studies of Unusual Leiomyoma
196 Leukotriene C4 Stimulating Factor from White Blood Cell in The Uterine tissue.
197 Direct inhibitory effects of prolactin in the process of ovulation.
198 The effect of free radical scavenger system on steroidogenesis according to age.
199 Changes of superoxide dismutase (SOD) activity and a-tocopherol(V.E.) concentration in the immature rats ovaries treated with PMSG and hCG.
200 Studies on the hystological changes and PRL localization in mammary and uterine tissues in hyperprolactinemic immature female rats.
201 Epidermal growth factor (EGF) receptor in porcine ovary.
202 Responses and cyclic change of the smooth muscle of the isolated guinea pig oviduct to autacoid.
203 Measurement of adrenergic neurotransmitter at egg transport in the rabbit oviduct.
204 Experimental studies on the oocyte handling by micromanipulation.
205 Effects of testosterone on the angiogenesis in the corpus luteum.
206 Glycolipid patterns of Balb/c mouse uterus depend on age and estrous cycle.
207 Fundamental study of energy metabolism by P-NMR spectroscopy in perfused rabbit ovaries
208 A study on the initiation and distribution of endometriosis.
209 Histogenesis of the gonads in human embryos.
210 Isolation and primary cultures of human fallopian tubal epithelium.
211 Production of Interleukin-6 by human trophoblasts.
212 Allospecificity of the syncytiotrophoblast of placenta villi.
213 Cytotoxic cells against trophoblasts during human spontaneous abortion.
214 Immunological studies in implantation site : Effects of plancental IgG and peripheral IgG on PHA induced T-cell mitogenesis
215 Detection of anti-idiotypic antibody in the sera of normal pregnant women.
216 Decreased production of sIL-2R and gamma IFN during pregnancy.
217 Flow cytometric detection of activated lymphocytes using monoclonal antibodies which recognize c-myc oncoprotein.
218 The surface markers, in vitro IL-2 production and NK activity of Tlineage cells in human decidua of early pregnancy.
219 Purification and biological effects of Pregnancy Zone Protein (PZP).
220 The role of Interleukin 1 in human amniotic fluids.
221 A study on Natural Killer cell in habitual aborters of unknown etiology treated by immunotherapy.
222 Possible mechanisms of HLA-immunotherapy for maintaining pregnancy against recurrent spontaneous aborters.
223 Effects of HLA antigens in reproduction.
224 Allospecificity of MLR-blocking antibodies and its relation to HLA-DA antigens.
225 The association of HLA compatibility with 120 couples after normal delivery.
226 Antiphospholipid antibody and reccurent fetal loss.
227 Analysis of a porcine zona glycoprotein family (23Kd) with common antigenicity to humans using monoclonal antibodies.
228 Studies on mechanism of blocking effect of sperm immobilizing antibodies on fertilization.
229 Common Carbohydrate Antigen Expressed on Human Trophoblast and Sperm.
230 Sperm immobilizing antibody neutralizing effect of IgG4 subclass in sterile women.
231 Chronological change of lipid metabolism in women and apolipoproteines in lipid-related deseases, cigarette smoking and alcohol ingestion.
232 Thermography in autonomic dysfunction.
233 Study on the chronological changes of lipid peroxide (LPO), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and reduced glutathione (GSH) levels in the human ovary.
234 Steroidogenesis and estradiol localization in postmenopausal ovaries.
235 Basic Study on about Reciprocal Relation Peripheral Circulation and Energy Metabolism of Muscle Follow Aging.
236 Bone metabolism variation in aging and castrated women : In paticular, the usefullness of osteocalcin as an index of bone metabolism
237 Region and mechanism of the decrease in bone mineral content due to oophorectomy.
238 Evaluation of the post menopausal bone mineral contents and bone metabolism.
239 Study of lumbadorsalgia, osteoporosis and post oophorectomy by DPA, MD, MD/MS and CR.
240 Serum osteocalcin level and lumbar bone density in pre- and post menopausal women.
241 Relationship between capacitation time of human spermatozoa and sperm cholesterol/phospholipid ratio.
242 Study for the acrosin proteolytic activity and the hyaluronidase activity in male infertility.
243 Correlation of sperm penetration assay results with the incidence of acrosome reacted sperm and sperm motility in suspension.
244 The sperm survival test, a new clinical sperm function test, assessing the change of sperm motility during long term incubation.
245 Analysis of pregnancy cases during administration of drugs to male infertility.
246 The effect of estradiol, progesterone and epidermal growth factor on prolactin production by cultured human decidual tissues.
247 The biological effect of Epidermal Growth Factor (EGF) on decidual cells.
248 Studies on the Role of Epidermal Growth Factor (EGF) in human Endometrial Decidualization.
249 Somatomedin C concentrations in maternal sera and in placental tissues
250 The study on biological roles of growth factors in cultured human trophoblast cells.
251 The action mechanism of GnRH in hCG release by human trophoblast cells : the role of calcium and protein kinase C.
252 Growth factors stimulasted by estradiol in endometrial neoplastic lesions.
253 Cooperative effect of TGF-β and EGF on the differentiation of mammary epithelial cells in culture.
254 Reciprocal action from steroids hormon to prostaglandin metabolism in human myometrium. : prostaglandin E_2 metabolism in human myometrium
255 Endometrial-myometrial interaction in prostaglandins production.
256 Treatment of uterine leiomyoma with danazol : Basal in vitro experiment by cell culture
257 Effect of danazol on steroidogenesis in cultured human luteal cells.
258 Concentration of CA-125, ThromboxaneB_2 and 6 keto-PGF_1 α levels in serum and tissues of women with endometriosis.
259 Purification of high molecular weight follicle-stimulating hormone receptor binding inhibitor (FSHRBI) in porcine follicular fluid.
260 Superfusion of Cultured Human Granulosa cells Attached to Cytodex Beads : The Self-Priming Effect of Follicle Stimulating Hormone and Effect of Prolactin on Steroidogenesis.
261 A study on the changes of aromatase activity and intra-cellular calcium (Ca) content of cultured human granulosa cells (G-cells) induced by FSH stimulation.
262 Plasma inhibin in pregnant women.
263 The hormonal characteristics in ovulatory disorders, especially about the serum inhibin concentrations.
264 Effect of porcine follicular fluid on the P450scc activity of cultured porcine granulosa cells.
265 Effects of Aromatase Inhibitor on the incorporation of Leucine into follicle, granulosa cell, and theca cell.
266 In vitro properties of pyridoglutethimide, a new selective aromatase inhibitor.
267 Effect of antiprogesterone steroid RU486 on human ovarian function.
268 Effect of RU486 on collagenolytic enzyme activities in immature rat ovary.
269 The role of progesterone in the ovulatory process in pMS-hCG treated immatured rats.
271 The effect of trans-4-(aminomethyl)-cyclohexanecarboxylic acid on ovulation in rat ovaries perfused in vitro.
272 The role of platelet activating factor in ovulation.
273 Involvement of tissue plasminogen activator activity in ovulation.
274 Isolation and Identification of Embryo-derived Platelet-activating Factor in mice.
275 Effects of serotonin and histamine on follicular steroidogenesis in the proestrous hamster.
276 Effects of GnRH on protein kinase C (PK-C) activity of the ovarian granulosa cells.
277 Possible existence of masked gonadotropin-binding sites for follicle-stimulating hormone (FSH) and the functionality of the binding sites in porcine granulosa cells (GCs).
278 Influence of Prolactin (PRL) on lipoprotein lipase (LPL) activity in rat fetal liver.
279 Involvement of lipoxygenase pathway on luteal function in human.
280 Impaired Glucose Tolerance in Patients with Polycystic Ovarian Disease (PCOD).
281 Lipid peroxide levels in ovariectomized female mice and the effect of administration of estrogen and catecholestrogen.
282 Effect of female hormones on the lipid peroxidation in placental tissue.
283 Gene expression of GnRH in the rat gonads.
284 Microheterogeneity and glycosylated structure of the human prolactin in the term amniotic fluid.
285 Identification of a promoter region in the hCGβ gene cluster.
286 Dynamics of nuclear T_3 receptor (NT_3 R) in human trophoblast and preparation of monoclonal anti-NT_3 R antibody.
287 Control of the synthesis of specific binding sites in estradiol-17 Beta and estriol by the ejection of estradiol and the relation with anti-estrogen effect.
288 Estrogen receptor ribonucleic acid in the rat uterus and the effect of estrogen.
289 Quantitative analysis for immunocytochemical study of steroid hormone receptors in human endometrial adenocarcinoma cells.
290 Control of local estrogen production by estrone sulfatase in human uterine myoma.
291 A study of non-aromatizing androgen 19-hydroxylase and C10-19 desmolase in human fetal adrenal tissue.
292 Insulin resistance during pregnancy : Glucose transport activity and insulin binding in isolated skeletal muscle of rats.
293 The effects of opioides peptides on the progesterone production by human placenta.
294 Human chorionic gonadotropin-like substance (hCG-LS) in postmenopausal women and its regulatory mechanism.
295 Immunohistochemical studies on epidermal growth factor (EGF), transforming growth factor-α (TGF-α) and EGF receptor (EGF-R) in carcinoma of the uterine cervix and ovarian tumor.
296 The relationship between Epidermal growth factor (EGF) and cellular atypism in precancerous lesions of the cervix.
297 Immunohistochemical studies on EGF receptor (EGF-R) in oncogenesis of the uterine cervical cancer.
298 Immunohistochemical studies on epidermal growth factor receptor (EGF-R) in gynecological malignant tumor.
299 Expression of type I and type II sugar Chain Antigen in Endometrial Tissue of the Uterus.
300 Different behaviors of production and release of SCC antigen in squamous cell carcinoma.
301 Immunohistochemical reactivities with anti-ATL derived factor (ADF) antibody in normal and neoplastic tissues of the uterine cervix.
302 Expression of fos and myc oncogene in uterine cancer
303 Immunohistochemical evaluation of ras oncogene product p21 in human endometrial lesions.
304 Relatioship between N-myc amplification and neuron-specific enolase production in the gynecological tumor cell lines.
305 Immunohistochemical observation of the Langerhans cells in squamous cell carcinoma of the uterine cervix.
307 Immunohistochemical localization of blood group antigens, HLA antigens, DNA polymeraseα and estrogen receptor in normal endometrium, endometrial hyperplasia and endometrial cancer.
308 A study of MTT assay for cell growth and chemosensitivity on the uterine adenocarcinoma cell lines and the effect of EGF.
309 Evaluation of chemosensitivity testing of the human uterine cervical carcinoma cell lines using MTT assay : study on the low dose and long course administration of Etoposide.
310 Human tumor clonogenic assay for gynecologic cancers.
311 Detection of humoral antitumor activity of regional lymph node lymphocytes in cervical cancer patients using human tumor clonogenic assay (HTCA).
312 Fundamental studies of Subrenal Capsule Assay : using malignant effusion.
314 Basic and clinical research of drug-resistant ovarian cancer.
315 Analysis of the levels of Sialyl SSEA-1 (SLX) in comparison with that of CA125 and CA199 in the gynecological disease.
316 Regulation of the production and secretion of tumor-associated antigens, TA-4 and hCG (α,β) by growth factors and signal transduction systems.
317 Effects of cytokine on expression of tumor antigen TA-4 in squamous cell carcinoma.
318 The relationship between DNA ploidy and post-irradiation uterie cervical cancer prognosis.
319 Flowcytometric and immunohistochemical analysis on gynecologic malignant tumors by monoclonal antibody of BrdU.
320 Flow cytometric analysis of DNA aneuploidy in female genital carcinoma.
321 Postoperative external radiation therapy in endometrial carcinoma.
322 Study on cervical adenocarcinoma as seen from radiosensitivity.
323 Experimental studies on irradiation effect with anticancer drugs.
324 Significance of para-aortic node irradiation in the treatment of cervical cancer.
325 Application of lymphadenectomy and intraoperative radiation therapy of the paraaortic lymph nodes in advanced cervical cancer.
326 Recurren Cervical Carcinoma after Radical Hysterectomy.
327 The prognosis of cervical cancer patients in reference to its radiosensitivity.
328 Antitumor effect of hyperthermia in the treatment of gynecological malignancy.
329 Intraperitoneal administration of OK432 followed by intraperitoneal rIL-2 (recombinant interleukin 2) on peritonitis carcinomatosa.
330 The clinical and experimental study of endogenous and exogenous TNF therapy.
331 An electron microscopic study of the histogenesis of the squamous epithelial component in endometrial adenosquamous carcinoma.
332 Stromal reaction surrounding the infiltrating apical area in cases of uterine cervical adenocarcinoma.
333 Ultrastructural studies on the basement membrane and the stroma in the endometrial adenocarcinoma, endometrial type.
334 Basic study of photo-dynamic therapy for the uterine cervix using excimer dye laser.
335 Possible existence of masked receptors for luteinizing hormone in the human corpus luteum during menstrual cycle and pregnancy.
336 Angiogenic activity of human villi and decidua in the first trimester of pregnancy.
337 Basic fibroblast growth factor-like substance in uterine and placental tissues of the pregnant rat.
338 Expression of renin, kininogen and kallikrein genes in the human placenta of IUGR pregnancy.
339 Gene expression of low density lipoprotein (LDL) receptor in human placenta during pregnancy.
340 Histological studies of the human placentas using quantitative morphometric analysis.
341 Effects of forskolin, phorbol ester and epidermal growth factor (EGF) on prolactin (PRL) production by human decidual cells.
342 Histochemical and ultrastructural studies on the localization of pregnancy specific beta-1 glycoprotein (SP1) in the chorion and the decidua of early pregnancy. : Using low temperature polymerized resin and protein A-colloidal gold method
343 The study on the platelet agrregation inhibitory activity of human placental synthiotrophoblast brush border.
344 In vitro trophoblast culture with CSF.
345 Studies on cell-connection of decidual-change and Fibronectin.
346 The study on the human placental L-lactate transport mechanism (The character and function of Na^+-H^+ exchanger in human placental brush border membrane).
347 Aminopeptidases in human placenta and other organs.
348 Progress of small GS with living embryo drawn from GS volume and CRL.
349 Treatment of Recurrent Abortion with Cord Blood Mononuclear cells.
350 Analysis of perinatal complications based on autoimmune-antibodies (AAs).
351 The involvement of antiphospholipid antibody in patients with habitual abortion or systemic lupus erythematosus (SLE).
352 Factors defining prognosis in pregnancies complicated by SLE.
353 Effect of exogenous endotoxin on uterine activity in pregnant goats.
354 Inbolvement of bacterial infection to abortion and preterm labor-Mechanism of uterine contraction due to bacterial infection.
355 The correlation between high surfactant level in amniotic fluid and chorioamnionitis in premature deliveries without PROM.
356 The clinicopathological value of acid soluble protein.
357 Clinical evaluation of CRP, sialic acid assay and intracervical culture on management of threatened premature labor and preterm PROM.
358 Comparison of aggressive vs conservative management in patients with premature rupture of the membranes (PROM).
359 Effect of terbutaline on preterm labor after ineffective intravenous ritodrine therapy.
360 Villitis of unknown etiology in placenta of small for gestational age infants and its relationship between toxemia of pregnancy and fetal anomaly.
361 Ultrastructural Features of Newly Formed Villi and its Primary Site of the Formation in Toxemic Placenta.
362 Ultrastructural observation of the arteries in the adherent part of the placenta in the IUGR cases, in paticular a comparative study with toxemia of pregnancy.
363 The relationship between pregnancy induced hypertension and fibronectin levels of maternal plasma.
364 Protein C inhibitor and its complex in normal pregnant and preeclamptic pregnant plasma.
365 The influence of increased uterine resting tonus on maternal blood pressure and angiotensin-II sensitivity.
366 Prediction of the occurrence of pregnancy induced hypertension(PIH) based on the changes in plasma PGI2 elicited by angiotensin II(A-II).
367 Atrial Sodium. Diuretic Horomon (hANP) in blood, Urine and Amniotic Fluid in Pregnancy.
368 The role of cyclic GMP in diurnal variation of urinary sodium excretion in pre-eclampsia.
369 Norepinephrine-induced contractions of isolated blood vessels of pregnant SHR given a saline load and inhibitory effects of Ca^<2+> antagonists.
370 Studies on the dynamics of Insulin-like Growth Factor-I (IGF-I) in Pregnancy induced Hypertension (PIH).
371 Erythrocyte filterability and carboxyhemoglobin in normal and preeclamptic pregnancy.
372 Taurine metabolism in platelets of patients with pregnancy induced hypertension.
373 Involvement of vasodilating and anticoagulant function of endothelial cells in pregnancy induced hypertension.
374 Development of an enzyme immunoassay for placental alkaline phosphatase and its application to gynecologic diseases.
375 Development of an enzyme immunoassay for placental tissue protein 17 and the possible clinical application.
376 The Clinical Value of the Measurement of Serum Sialyl SSEA-1 Antigen Levels in Patients with Gynecologic Disease.
377 Studies of the diagnosis and follow for patients with suspicious endometrial smear test.
378 Clinical usefulness of determination of CA 125 and E_2 levels in the serum and menstrual blood for patients with endometriosis.
379 Blood Fibronectin Level as an Index of the Risk of Relapse for Endometriosis.
380 Fundamental and clinical studies on new detection kit for human papilloma virus.
381 Usefullness of Magnetic Resonance Imaging on the Uterine Diseases.
382 Predictive value of CT scan in assessing pelvic node metastases of untreated cervical carcinoma.
383 Evaluation of chorionic villus sampling (CVS) by Fujinon flexible hysterofiberscope and investigation of infants after CVS.
384 The obervation on the early pregnancy by transvaginal ultrasound.
385 Investigation of ultrasonographic diagnosis of cervical incompetence by using TV-probe.
386 Reevaluation of the diagnosis of placenta previa in mid-trimester : transvaginal approach with high-frequency ultrasonography.
387 Characteristics of ultrasound imaging in fetuses with trisomy 18.
388 The determination of optical conditions of FCR in pelvimetry and the reduction of radiation dose to mother and fetus.
389 Clinical significance of non-invasive evaluation method for fetal physiolosical state.
390 Analysis of impedance cardiography longitudinally applied in pregnancy.
391 The Prediction of Respiratory Distress Syndrome with Multivariable Analysis.
392 Carrier diagnosis of Norrie Disease (ND) using DNA polymorphism.
393 Application of flow cytometry in scoring acrosome reacted human sperm.
394 Interference with sperm migration by sperm immobilizing antibody in the female genital tract from uterine cavity to fallopian tubes.
395 A clinical study of single and combined therapy of Bromocriptine (Br) for hyperprolactinemic and occulted hyperprolactinemic infetile women with menstrual disorders.
396 Revision of estradiol-17β radioimmunoassay : Specific and highly sensitive method.
397 The value of human serum inhibin measurement for prognosing the outcome of pregnancies in IVF-ET and GIFT.
398 The fetal abnormality screening with tumor markers.
399 Simplified method for quantification of aminopeptidases in pregnant serum and it's clinical significance.
400 Maternal serum α-fetoprotein (MSAFP) in pregnancies with newborn anomalies.
401 Value of antimicrosomal antibody on screening of postpartum thyroid dysfunction.
402 Possibility of screening for abnormal glucose tolerance during pregnancy before 20 weeks' gestation.
403 Effect of time interval between a breakfast and a glucose challenge test on the sensitivity of the screening test for abnormal glucose tolerance during pregnancy.
404 A study on the endometrial movement in connection with hormonal level and uterine contraction.
405 Fragmentation of the β-subunit of hCG in urine of the patient with choriocarcinoma.
406 Management of trophoblastic disease patients by commercial hCG kits.
407 Effect of anti-idiotypic antibody to measurement of beta-hCG titer in trophoblastic disease.
408 MTX Resistant Mechanism in Human Choriocarcinoma Cells.
409 Development of androgenetic diploid eggs in the mouse.
410 Studies on the pathogenesis of choriocarcinoma by DNA fingerprinting.
411 Effects of various growth factors on the growth of trophoblast cells in vitro.
412 The study of the localization of c-onc mRNA in choriocarcinoma cell line with In-situ hybridization.
413 The Ca sensitivity of contractile proteins of chemically skinned muscle fibers by saponin of human pregnant uterus.
414 Reconsideration of CA125 expression from the embryonic viewpoint.
415 Serum CA130 levels of women in normal pregnancy and in the menstrual cycle, using new immunoradiometric assay (IRMA) with two monoclonal antibodies (130-22,145-9).
416 Heterotransplantation of argyrophil small cell carcinoma of the uterine cervix into nude mice.
417 Histological and immunohistological studies on the repairment of cervix after CO_2 laser conization.
418 Endometriosis and autoantibodies - with special reference to antiphospholipid antibodies.
419 Humoral cotrol mechanism during endometrial regenerative process.
420 Immunohistochemical localization of peroxidase on endometrial cancer using monoclonal antibody.
421 Amylase of the uterine endometrium.
422 Immunohistochemical Localization of Glutathione Peroxidase in Normal and Cancerous Endometria.
423 Histochemistry of the endometrium : With special reference to keratan sulfate-like and Griffonia Simplicifolia aggulutinin-I-B4 (GSA-I) reactive sugars.
424 Fundamental investigation of collagen fiber in the human decidual tissue.
425 Ultrastructural observations on short-term cultured endometrial cells from virgin rabbits and rabbits at 6 1/2 days after mating.
426 Studies on the Cardiotocograms Recorded by a flexible ultrasound transducer.
427 Sister chromatid exchanges in mouse after exposure to pulse-wave ultrasound in utero.
428 Quantitative analysis of fetal heart rates using a probability matrix.
429 Doppler ultrasonographic assessment of fetal cardiac time intervals.
430 Spectral analysis on FHR signals in normal human fetuses at term.
431 Assessment of fetal circulation with arterial and intracardiac blood flow parameters.
432 Evaluation of fetal structural heart disease using color flow mapping.
433 Periodic Fetal Respiratory Movement accompanied with sinusoidal FHR pattern by Fetal Actocardiogram.
434 Relationship between the placental location and the flow velocity waveform of bilateral uterine artery.
435 Qualitative Evaluation of Uterine Contractions Recorded by the Double Guard-Ring Tocodynamometers.
436 Electrical Uterine Activity in Pre-term Contractions.
437 The study of bioenergetics of mouse pregnant uterine muscle by magnetic resonance spectroscopy (MRS).
438 Development of the Micro Optical Analysis of the Amniotic Fluid by the Vacuum-dried Infrared Attenuated Total Reflection (ATR) Method (the second report).
439 The study of the mechanism of the climacteric symptoms by measuring the microcirculation with the laser-Doppler blood flow meter : Basic study and correlation with Kupperman's index.
440 Artificial Intelligence for Perinatal Management, Using the Fuzzy Theory.
441 Multipatients fetal home monitoring : application of bidirectional transmission line with time-axis compression.
442 Clinical evaluations of the vaginal operation for genital prolapse : clinical data obtained from 151 cases.
443 Chain cystogram and uroflowmetry for the preoperative and postoperative assessment of cystocele and uterine prolapse.
444 Surgical treatment for huge or multiple intramural fibroids in early pregnancy.
445 Laparoscopic treatment of unruptured tubal pregnancy with intratubal methotrexate injection.
446 Transcervical Tubal Recanalization (TTR) of cornual occlusion.
447 Transcervical resection (TCR) of uterine septum with resectoscope.
448 Trial of intrauterine treatment by YAGlaser balloon method.
449 Early second look laparoscopy (ESLL) after conservative operations to prevent postoperative adhesions.
450 A new method to prevent postoperative adhesion by fibrin film.
451 Study on pelvic and paraaortic lymphnode metastases in uterin cervical cancer.
452 Clinical significance of an subcutaneously implantable catheter in terminal cancer patients.
453 Labor control under epidural anesthesia : β endorphin levels in perinatal mothers and fetuses.
454 Functional examination of peritoneal macrophage in endometriosis patient : infertility factor determination.
455 Activity of Peritoneal Macrophages and Interleukin-1 in Endometriosis.
456 Suppression of in vitro development of mouse embryos by endometriosis peritoneal fluid and Danazol effects.
457 The relationship between laparoscopic appearance of endometriosis and prostaglandins in the peritoneal fluid.
458 Effects of gestrinone (R2323) on ovulation and oocytes characteristics in the rabbit.
459 Effects of an antiprogestin, RU486 in human chorion during early pregnancy.
460 Contribution of embryo-derived platelet activating factor in pregnancy establishment in mice : a study with a PAF antagonist, CV-6209.
461 Effects of saccharides on human fertilization.
462 The effect of protein supplement on mouse in vitro fertilization and embryo development.
463 Zonae pellucidae of salt-stored eggs : Their functions in sperm-zona interactions.
464 Production of antisera to each 4 glycoprotein family of porcine zona pellucida and their inhibitory effect on sperm-zona binding.
465 The effects of fibronectin and its peptide fragment on early embryo development.
466 Ultrastructural changes of ova during degeneration.
467 Effects of superoxide dismutase on 2-cell block in mouse embryos cultured in vitro.
468 An experience of pure FSH ovulation induction for in vitro fertilization.
469 A comparative study of clomid-HMG and HMG for follicular stimulation in IVF-ET/GIFT treatment.
470 Relationship between serum estradiol level and results of in vitro fertilization and embryo transfer (IVF-ET).
471 Effect of Immunotherapy in Infertile Couples of in vitro fertilization-embryo tubal replacement (IVF-ETR) failure.
472 Results of IVF-ET on outpatient bases.
473 Effect of human amniotic fluid with glycerol or propanediol on quick freezing of mouse embryos.
474 Cryopreservation of early stage mouse embryo and its effect on chromosome.
475 Effects of trehalose as a dilution and cryoprotectant on the survival of 2 cell stage mouse eggs after freezing and thawing.
476 Assessment of inhibin concentrations with results in program of in vitro fertilization embryo transfer.
477 Effect of platelet activating factor on in vitro fertilization and embryonic development in mice.
478 cAMP levels and degradation rate in human follicular fluid: Their relationship to fertilization and cleavage of oocytes in vitro.
479 Development of the glucose utilization sysytem in the fertilized oocytes and preimplantation embryos from mice.
480 A possible role of progesterone on the RNA synthesis of mouse preimplantation embryo.
481 Intrauterine insemination with ovarian stimulation and Percoll separated spermatozoa.
482 Sperm recovery from peritoneal fluid after intrauterine insemination at diagnostic laparoscopy-analysis of 1124 infertile patients.
483 Comparison of the clinical results obtained from three different sperm preparation methods used for AIH.
484 Pregnancies product by hysteroscopical insemination into an oviductal tube.
485 Effect of LH surge on oocyte maturation, fertilization, cleavage and pregnancy.
486 Effect of LHRH analogue on folliculogenesis in hypergonadotropic hypogonadism
487 Effect of transient hyperprolactnemia at ovulatory phase on maturation of human oocytes.
488 Nomal lutelal phase progesteron (P) level in relation to the duration of high basal body temperature (BBT) phase and endometrial histology.
489 Studies on the regulatory mechanism of human endometrial decidualization.
490 Hysteroscopic endometrial dating.
491 Influence of Serum Progesterone/Estradiol ratio in luteal phase for achieving pregnancy.
492 Conservative treatment of ectopic pregnancy with methotrexate, etoposide and embryocide.
493 The effect of thyroxine administration on hypothalamic-pituitary-ovarian function in hypogonadal women.
494 Change of rat fetal and maternal hypothalamic corticotropin-releasing factor content caused by acute stress in late pregnancy.
495 Effects of the selective dopamine receptor agonists B-HT 920 and SND 919 on prolactin and oxytocin secretion in rats.
496 Relationship between tyrosine hydroxylase- and LHRH-containing neurons by means of double labeling immunocytochemical technique.
497 The stimulatory effect of histamine on LH-RH secretion in vitro.
498 Effect of 2-buten-4-olide, an endogenous feeding suppressant, on hypothalamo-pituito-ovarian axis.
499 Effects of gonadal steroids on gonadotropin secretion : studies with perifused rat pituitary cells.
500 A correlative radioimmunoassay and immunohistochemical study on the sex difference in pituitary gonadotropin storage in maturing rats.
501 The synthesis and release of gonadotropins of the rat anterior pituitary gland during weight reduction.
502 Pattern of nocturnal serum melatonin in follicular and luteal phase and relation to the LH, FSH and prolactin secretion.
503 Inhibition by islet-activating protein of dopamine action on TRH-induced prolactin release in pituitary cells.
504 Clinical features and treatment of bromocriptine (Br.) in hyper-LH syndrome.
505 The mechanism of the effect of combination treatment with clomiphene and bromocriptine in patients with normoprolactinemic anovulation.
506 Study on the positive feedback effect of estrogen on gonadotropin release in secondary anovulatory women with normoprolactinemia.
507 Pulsatile release of gonadotropins in athletic women.
508 Catecholamine and hormone change by physical exercise in nonathletic cycling women.
509 CLINICAL USEFULNESS OF MEASUREMENTS OF 11-DEOXY-17-KS CONJUGATES IN WOMEN WITH MENSTRUAL DISORDERS.
510 Sex hormonal influence on X-chromatin frequency in vaginal smears.
511 Analysis on immunohistochemical localizations of LH, FSH, estradiol and testosterone in stromal components of human ovary.
512 A case of successful treatment of Benign Metastasizing Leiomyoma of the uterus with oophorectomy.
513 Remission cases of Prolactinoma after pregnancy and delivery.
514 Emergency Care of Obstetric and Gynecologic Patients in the Osaka-Kobe Area : Analysis of obstetric and gynecologic patients transported to hospitals by ambulance in 10 local communities in the Osaka-Kobe area and the problems of the current patient transport system.
515 A case of Sertoli-Leydig cell tumor associated with high serum concentration level of AFP.
516 A case of simultaneous pregnancy in each cavity of uterus bicornis unicollis with rudimentary horn that resulted in both neonatal survival after two episodes of uterine rupture.
517 Organ preservation of the isolated human uterus.
518 The assessment of gynogenetic origin of early abortion by DNA fingerprint method on chorionic villi.
519 Personality characteristic of the patients with threatened midtrimester abortion and premature delivery.
520 Miliary tuberculosis presenting as respiratory failure during pregnancy.
521 Hyperthecosis and its endocrinology.
522 Establishment of indirect immunofluorescence staining (IF) for detecting antibody to human parvovirus B19 and the prevalence of it in pregnant women.
523 Detection of HTLV-I genome in infants born to HTLV-I seropositive mother by polymerase chain reaction.
524 Protective effect of artificial nourishment and freeze-thawing breast milk feeding on HTLV-I mother to child infection.
525 Detection of HTLV-1 antigen in the peripheral blood of "ATL carrier" and cord blood at the delivery.
526 ATLA antibody screening in pregnant women and significance of Western Blot (WB) method as a secondary test.
527 Diagnosis of HTLV-I infection by polymerase chain reaction (PCR).
528 Selective suppression of human papilloma virus type18 m-RNA level in Hela cells by interferon.
529 Rubella reinfection of the pregnant women and intrauterine infection, including the problem of the routine vaccination.
530 Studies on rubella specific IgM in fetuses whose mothers had confirmed rubella in pregnancy.
531 Significance of chlamydia trachomatis antibody determination in obstetrical and gynecological infections.
532 Detection of Chlamydia Trachomatis (CT) Infection in Prenatal Stage for Preventing the Birth Canal Infection.
533 The influence of pregnancy and delivery on HBV amount of HBeAg-positive carrier mothers.
1 Steroid receptors in endocrine therapy of endometrial carcinoma.
2 Modulation of cellular immunity by opioid peptides in nude mice bearing human ovarian carcinoma.
3 Overcoming of multidrug resistance by newly synthesized dihydropyridine analogs.
4 Evaluation of the combined therapy with MPA and VCAP chemotherapy for advanced or recurrent endometrial cancers.
5 Prognostic significance of the pattern of carcinoembryonic antigen (CEA) localization in squamous cell carcinoma of the uterine cervix.
6 Altered expression of Lewis blood group and related antigens in fetal normal adult and malignant tissues of the uterine endometrium.
7 Distribution of basement membrane antigens in adenocarcinomas of the uterine cervix, an immunohistochemical study.
8 An Immunohistochemical Study on Tumor-infiltrating Lymphocytes in Cervical Neoplasms.
9 Analysis of peripheral T lymphocyte subsets in patients with carcinoma of the cervix uteri.
10 Study for histogenesis of Paget's disease of the vulva.
11 Investigation of antineoplastic agents screening test using sister chromatid exchange assay (SCEA) : Applications of SCEA for sensitivity of time-dependent agents.
12 DNA analysis by Flow Cytometry in gynecologic solid tissue neoplasms.
13 Fundamental study of anti-tumor effects of laserthermia on uterine cervical cancer.
14 Effect of remission induction chemotherapy on blood coagulability in patients with gynecological malignancies.
15 Histopathological study on glandular dysplasia of the uterocervix.
16 Assessment of magnetic resonance imaging (MRI) in evaluating extension of endometrial carcinoma : in comparison with computed tomography (CT).
17 Immunohistochemical approach to reveal the growth potential of uterine cancer using anti-BrdU antibody and Ki-67.
18 The expression of ras oncogene product p21 in the carcinogenesis of cervical squamous epithelium.
19 Immunohistochemical and serological studies on detectoin of SCCAA in precancer and/or cancer of uterine cervix.
20 Immunohistochemical studies on EGF receptor (EGF-R) and ras oncogene product (P21) in experimental squamous cell carcinoma of the uterine cervix of mice.
21 Detection of human papilloma virus in cervical lesion using PCR (polymerase chain reaction).
22 A study of ovarian cyst using Magnetic Resonance Imaging with special reference to its use in diagnosis of endometrial cysts.
23 The Immunohistochemical analysis for the reactivity of MoAb, NCC-CO-450 against ovarian cancer.
24 ABH and Lewis Blood Group Expression in Ovarian carcinoma.
25 Circulating tumor-associated antigen detected by the murine monoclonal antibody CF511 in human epithelial ovarian carcinoma.
26 Ultrastructural localization of CA125 in the serous cystadenocarcinoma using monoclonal antibody 130-22 (CA-130).
27 EVALUATING TREATMENT PLAN, THERAPEUTIC EFFECTS AND PROGNOSIS OF OVARIAN CANCER USING TUMOR MARKER DOUBLING TIME OF CA125.
28 Cross resistance of human ovarian cancer cells to Cisplatin and Adriamycin.
29 Prevention of renal failure after intraperitoneal chemotherapeutic perfusion (IPCP) with MMC and intraperitoneal administration (IP) of cisplatin (CDDP) in cases of ovarian cancer (O-C).
30 Effect of chemotherapy (CAPF) on Peripheral Lymphocyte Subpopulations in Ovarian Cancer.
31 Field trial for the early detection of patients with ovarian cancer in Shizuoka prefecture.
32 Quantitative analysis of digital subtraction angiography in invasive mole.
33 Expression and Amplification of C-oncogene in the Trophoblastic Disease.
34 Combination therapy of OK-432 and etoposide on liver metastatic lesions of ovarian cancer.
35 Establishment and characterization of mouse pulmonary adenocarcinoma cell line (KBLC) as a model for the study of surfactant biosynthesis.
36 Prenatal Diagnosis of an Aneurysm of the vein of Galen.
37 The statistical analysis of the 16years' investigations for congenital malformations in Japan.
38 A report of peripartum course in a patient with congenital factor XII deficiency.
39 The incidence of congenital malformations in infants of diabetic mothers in Japan.
40 Perinatal management of patients with hemodialysis.
41 New useful management of fibrin adhesion for premature rupture of the membranes during second trimester of pregnancy.
42 The expression of anti-phospholipid antibodies in patients with recurrent abortions or IUFDs.
43 Increased vascular sensitivity to Angiotensin II (A-II) on pregnant rabbits under chronic increased intra-uterine resting tonus.
44 Maternal urinary catecholamine (CA) excretion during pregnancy and the neonatal development of their offsprings in SHRSP.
45 Nifedipine dose not affect uteroplacental blood flow in the hypertensive pregnant rat.
46 Effect of Ca-blocker (nifedipine) and dipyridamole on umbilical and uterine arterial blood flow.
47 The acute effects of calcium on vascular sensitivity to angiotensin II in perfused rat hindquarters.
48 Amniotic fluid embolism and leukotrienes : Effect of trypsin on leukotriene production.
49 Analysis of human alpha-amylase in the ammniotic fluid using the pH titration curve method.
50 Effects of high concentrated steroids on phosphatidylinositol-phospholipase C activity in gestational human myometrium.
51 Effects of ritodrine on spontaneous contractions of pregnant rat myometrium.
52 A possible role of estrogen and progesterone in the regulation of plasma levels of vitamin B_12 binding protein (transcobalamin:TC) during pregnancy.
53 The effect of tread-mill exersise under pregnancy.
54 Investigation of sialate and its related negative charging on the syncytiotrophoblastic surface of the preeclamptic term placentae.
55 Proliferative potential of trophoblast cells.
56 Ultracytochemical localizations of oxygen-intermediates metabolozing enzymes in the human placenta, with special reference to NADH oxidase.
57 Analysis of trophoblast subpopulations which appear on touch smears of chorionic villi during normal pregnancy.
58 Ultrastructure of Cytochemical Localizations of Adenylate Cyclase, Mg^<++>- ATPase and ALPase in the Pregnant Mouse Uterine Endometrium.
59 Isolation and differentiations of mature placental cytotrophoblast in culture.
60 Study of Preterm Labor Induced by Experimental Chorioamnionitis.
61
62 Clinical Studies on Prevention of HTLV-1 Transmission via Breast Feeding.
63 Change in the T/QRS ratio during progressing fetal acidemia caused by repeated umbilical cord occlusion in electrocardiogram in chronically instrumented lamb fetuses.
64 Ultrasonographic measurements of fetal and neonatal spleen.
65 Color and pulsed Doppler ultrasonographic assessments of fetal renal arterial blood flow velocity waveforms.
66 Analysis of Utero-placento-fetal system by means of pulsed Doppler and biochemical method.
67 The diagnostic accuracy of intrauterine growth retardation (IUGR) by ultrasound and endocrine tests.
68 Development of a new finger-tip probe for transvaginal echography.
69 Transition of ovarian arterial compliance during the human menstrual cycle, assessed by Doppler ultrasound.
70 The study of temperature control mechanism between mother and fetus.
71 Effect of acute respiratory acidosis on fetal movements in chronically instrumented fetal lambs.
72 A 19-year review of the effects of advances in perinatal management on the outcome of malformed fetuses.
73 Significance of Measurement of Molecular Markers of Endethelial Cells in PIH.
74 The Clinical Singnificance of Fetal Blood Sampling.
75 Nutritional and physiological role of taurine during perinatal period.
76 Metabolism of unsaturated fatty acids in maternal and fetal rabbits.
77 Changes of the levels of Oxytocin, Estrogen stimulated Neurophysin, and Steroids in maternal peripheral blood during late pregnancy and labor.
78 Study on pulsatility in sex steroids and LH secretions in luteal phase defect.
79 Study for the prolactin (PRL) secreting and synthetic capacity of pituitary gland with BCP (bromocriptine)-TRH test.
80 Epidermal Growth Factor (EGF) in urine of pregnant women and in amniotic fluid throughout pregnancy.
81 Metabolic pathway to form estriol in the placenta : substrate specificity of microsomal and purified aromatase.
82 Inhibitory effect of interleukin 1(IL-1) on the aromatase (A) activity in cultured rat granulosa cells.
83 The inhibitory effect of 14_α-hydroxy-4-androstene-3,6,17-trione (14・OH-AT) and its derivatives on aromatase in various human tissue preparations.
84 Studies on the mechanism of antiestrogen effects of gestrinone.
85 The role of DHAS as substrate for ovarian steroidogenesis.
86 Effect of epidermal growth Factor (EGF) on the release of prostaglandins (PGs) from cultured human endometrial cells.
87 Steroid hormone recognition mechanism in human endometrial fibroblasts : Transmembrane signalling.
88 The effects of steroid hormones on glycogen metabolism of a human endmetrial adenocarcinoma cells.
89
90 Immunohistochemical localization of peptides and catecholamine synthesizing enzyme, tyrosine hydroxylase (TH) in the ovary of the rat.
91 An antigonadotropic factor in the urine of pregnant women.
92 Detection of GnRH mRNA in the pregnant rat uterus.
93 A study on the viability of frozen mouse embryo.
94 Effect of protein supplement and potassium concentration on mouse 2-cell embryo development in vitro.
95 Assisted fertilization of the mouse and human oocytes by creating a small opening in the zona pellucida.
96 The treatment of asthenospermia by the method of sperm injection into perivitelline space.
97 Results of zona-free hamster egg sperm penetration test (ZSPT) : A prospective study of 491 infertile patients with oligospermia.
98 Correlation of serum progesterone and inhibin levels with outcome of pregnancy in program of in vitro fertilization embryo transfer.
99 The role of fibronectine and fibronectine receptor on implantation.
100 Observation of Localization of Fibronectin on Human Spermatozoa by means of Backscattered Electron Imaging Method.
101 Is it true that poly cystic ovary syndrome is one of the indications of bromocriptine?.
102 Major histocompatibility antigen on human sperm.
103 Antitumor efffect of OK-432 and rIFN-γ in patients with ovarian carcinoma.
104 Depression of Interferon-γ Production by Peripheral Blood Mononuclear Cells in Cervical Cancers.
105 The cytoimmunological effect of concomitant use of sizofiran (SPG) on advanced uterine cervical cancer treated with radiation : Peripheral and intra-tumor.
106 The immunological significance of decidual supernatant on maintaining pregnancy : Its effect on LAX activity of peripheral blood mononuclear cells (MNC).
107 Studies on the mechanisms of unfavourable immunoglobulin production in premature and term infants and the effcts of humoral factor in the recovery of immunoglobulin production in preterm and term infants.
108 1 case of Healyn-Werner syndrome and 2 cases of uterovaginal anomalies associated with unilateral renal agenesis.
109 Dysgerminoma and gonadoblastoma in a phenotypic female with 45, X/47, XYY mosaicism.
110 Blockage of the Umbilical Blood Flow of Acardiac Monster in Utero.
111 Severe Pre-eclampsia (HELLP syndrome) complicated with Multiple Organ Failure (MOF). Successful Therapy with Hemodialysis (HD) and Plasma exchange (PE).
112 A case of pregnancy complicated with congenital antithrombinIII deficiency.
113 Histpathological study of hemangioendothelioma in the uterus : A case report.
114 Basic and clinical studies of puncture-drug injection therapy under ultrasonography for ovarian tumor.
115 Comparison of screening test for ATL virus carrier.
116 Study of Rapid Diagnosis of Chlamydia Trachomatis Infection on the Fields of Obstetrics and Gynecology.
117
118 Evaluation of the usefulness of Magnetic Resonance Imaging for analysis of the invasion of uterine cervical cancer.
119 Diagnosis of ovarian tumors with MRI.
120 Clinical studies on new immunoradiometric assays for measurement of serum LH and FSH using pituitary gonadotropin standards.
121 A comparative study between hysteroscopic and histologic findings of endometrial hyperplasia.
122 Usefulness of Electric Endoscope in Obstetric and Gynecological Field.
123 Flow-cytometric analysis of cell surface antigen of endometrial carcinoma.
124 Ultrasonographic detection of molar pregnancy and its significance.
125 Application of MTT assay in Sensitivity test for Anti-tumor Agents and its Clinical Effect.
126 P-450 in Human Fetal Livers (P-450HFLa) : The Possible Clinical Application Based on The Results of The Immunohistochemical Investigation and EIA.
127 Assessment of fallopian patency by transvaginal ultrasound.
128 Diagnosis of early ectopic pregnancy by transvaginal ultrasonography.
129 Serial ultrasonic examinations on ovarian tumors in pregnant women.
130 Characteristic ultrasonographic findings of the metastatic ovarian cancer.
131 The evaluation of fetal heart rate and umbilical blood flow velocity waveforms respose to vibratory acoustic stimulation.
132 The study on the indirect measurement of the blood pressure of neonates by means of the acceleration plethysmogram method.
133 DIAGNOSIS OF IUGR BY ULTRASOUND MEASURED FETAL PROPOTION.
134 Maternal serum and amniotic fluid α-fetoprotein (AFP) in the mid trimester of pregnancy for the screening of fetal chromosomal anomalies.
135 Immunohistochemical investigation of Membrane-associated placental tissue protein 2 (MP_2).
136 Studies on the relationship between serum Type III Procollagen Peptide levels and fetal development during pregnancy.
137 The clinical significance of dehydroepiandrosterone sulphate (DHAS) half-life in the third trimester.
138 Analysis of diagnostic criteria for evaluating breech CPD in Japan.
139 The evaluation of Gonadotoxicity of anti-cancer drugs (VP-16, MTX, Act-D).
140 Cumulus Oophorus facilitates fertilization in vitro in the mouse.
141 Comparison between serum levels and Immunohistochemical examination of CA125 and CA19-9 in endometriosis.
142 Serial changes of serum CA125 levels during menstrual cycles with normal luteal phase, luteal insufficiency and anovulation.
143 Immunohistochemical and morphological observations of macrophages in the human ovary.
144 Swollen cilia in fallopian tube.
145 Immunohistochemical localization of vimentin in the human ovary.
146 Cyclic change of prostaglandins production in the human falloian tube.
147 Contractile responses and prostaglandin biosynthesis induced by field stimulation and adenosine 5'-triphosphate in rabbit uterine muscle.
148 Immunohistochemical characteristics of reserve cells in uterine cervix and the appearance of antigenicity in vitro.
149 SEM observation of the transition from endometrial to endocervical epithelium in the human uterus.
150 Immunohistochemical study of extravillous trophoblast for new placental proteins.
151 Cerebral cortical blood flow and oxygen utilization in women with climacteric symptoms and complaints.
152 The effect of tranquilization-training capsule (BLESS MAHC) on the human neuroendocrine function.
会員入退会
地方部会の動き
学会研究会案内
7月受付原稿
読者からの手紙に関する投稿規定
裏表紙
CONTENTS
